Imexpharm (STC:IMP) Cyclically Adjusted Book per Share: ₫13,437.60 (As of Mar. 2026)


STC:IMP Imexpharm Corp STC:IMP
98 GF Score
Price ₫42,050.00
GF Value ₫51,706.57
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Imexpharm Cyclically Adjusted Book per Share?

Imexpharm STC:IMP -1.98% 98 Cyclically Adjusted Book per Share is ₫13,437.60 as of Mar. 2026. GuruFocus rates STC:IMP with a GF Score™ of 98/100 and a GF Value™ of ₫51,706.57 (Modestly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Imexpharm's adjusted book value per share for the three months ended in Mar. 2026 was ₫15,444.167. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₫13,437.60 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Imexpharm's average Cyclically Adjusted Book Growth Rate was 6.50% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 5.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Imexpharm was 6.80% per year. The lowest was 5.90% per year. And the median was 6.35% per year.

As of today (2026-06-28), Imexpharm's current stock price is ₫42050.00. Imexpharm's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was ₫13,437.60. Imexpharm's Cyclically Adjusted PB Ratio of today is 3.13.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Imexpharm was 4.27. The lowest was 1.81. And the median was 3.21.


Imexpharm  (STC:IMP) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Imexpharm's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=42050.00/13437.60
=3.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Imexpharm was 4.27. The lowest was 1.81. And the median was 3.21.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Imexpharm Cyclically Adjusted Book per Share Related Terms


Imexpharm Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Imexpharm's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imexpharm Cyclically Adjusted Book per Share Chart

Imexpharm Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10,138.02 10,996.33 11,617.26 12,345.15 13,077.69

Imexpharm Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12,611.63 12,812.56 12,998.37 13,077.69 13,437.60

STC:IMP vs ZTS: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Imexpharm's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Imexpharm Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Imexpharm's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Imexpharm's Cyclically Adjusted PB Ratio falls into.


STC:IMP
98GF Score
Imexpharm Corp STC:IMP
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Imexpharm Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Imexpharm's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=15444.167/330.2130*330.2130
=15,444.167

Current CPI (Mar. 2026) = 330.2130.

Imexpharm Quarterly Data

Book Value per Share CPI Adj_Book
201606 7,562.018 241.018 10,360.540
201609 7,758.981 241.428 10,612.342
201612 8,386.423 241.432 11,470.335
201703 9,057.073 243.801 12,267.231
201706 9,067.109 244.955 12,222.969
201709 9,215.200 246.819 12,328.787
201712 9,262.759 246.524 12,407.244
201803 9,401.360 249.554 12,439.998
201806 9,585.237 251.989 12,560.746
201809 9,819.870 252.439 12,845.276
201812 9,989.063 251.233 13,129.320
201903 10,229.589 254.202 13,288.421
201906 9,762.527 256.143 12,585.600
201909 10,010.848 256.759 12,874.766
201912 10,351.740 256.974 13,302.043
202003 10,624.757 258.115 13,592.518
202006 10,535.558 257.797 13,495.030
202009 11,008.170 260.280 13,965.886
202012 11,236.121 260.474 14,244.467
202103 11,507.890 264.877 14,346.489
202106 11,015.416 271.696 13,387.880
202109 11,218.771 274.310 13,505.100
202112 11,651.181 278.802 13,799.655
202203 11,992.724 287.504 13,774.255
202206 11,493.465 296.311 12,808.473
202209 11,855.709 296.808 13,190.039
202212 12,300.725 296.797 13,685.648
202303 12,806.054 301.836 14,010.010
202306 12,612.896 305.109 13,650.670
202309 13,065.492 307.789 14,017.380
202312 13,535.348 306.746 14,570.843
202403 13,937.401 312.332 14,735.317
202406 13,490.448 314.175 14,179.108
202409 13,960.696 315.301 14,620.960
202412 14,175.270 315.605 14,831.382
202503 14,593.824 319.799 15,069.060
202506 13,779.330 322.561 14,106.212
202509 14,278.598 324.800 14,516.560
202512 14,976.541 324.054 15,261.187
202603 15,444.167 330.213 15,444.167

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ₫13,437.60 mean?
Imexpharm (STC:IMP) has a Cyclically Adjusted Book per Share of ₫13,437.60 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Imexpharm and its competitors.
Is Imexpharm's Cyclically Adjusted Book per Share too high?
Imexpharm's current Cyclically Adjusted Book per Share is ₫13,437.60. Overall, Imexpharm has a GF Score™ of 98/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Imexpharm's Cyclically Adjusted Book per Share compare to ZTS?
Imexpharm's Cyclically Adjusted Book per Share of ₫13,437.60 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Imexpharm and its competitors. Imexpharm's current Cyclically Adjusted Book per Share is ₫13,437.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imexpharm stock overvalued right now?
Based on GuruFocus' analysis, Imexpharm (STC:IMP) is currently considered Modestly Undervalued. The stock's GF Value™ is ₫51,706.57, compared to a current price of ₫42,050.00 — trading 18.7% below its estimated fair value. The current Cyclically Adjusted Book per Share is ₫13,437.60. Imexpharm's overall GF Score™ is 98/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Imexpharm (STC:IMP), the current Cyclically Adjusted Book per Share is ₫13,437.60 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Imexpharm (STC:IMP) Overvalued in 2026?

Based on GuruFocus' analysis, Imexpharm stock appears to be undervalued. The current stock price of ₫42,050.00 is trading 18.7% below its estimated GF Value™ of ₫51,706.57. GuruFocus considers Imexpharm to be Modestly Undervalued.

Key valuation signals for STC:IMP:

  • Cyclically Adjusted Book per Share: ₫13,437.60
  • GF Value™: ₫51,706.57 vs. price of ₫42,050.00 (18.7% below fair value)
  • GF Score™: 98/100 with 2 warning signs

No single metric tells the full story. See the STC:IMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Imexpharm Business Description

Address 4 Road 30/04 Street Ward 1, Cao Lanh City, Dongthap, VNM
Imexpharm Corp is engaged in the manufacture, import, export, and trade of pharmaceuticals and medicinal chemical products. The company's products include oral and injective antibiotic, digestion, central nervous system, cardiovascular, diabetes, musculoskeletal system, respiratory system, analgesic-anti-inflammatory, anti-allergy, ophthalmology, external drugs, and anti-parasitic, as well as vitamins and minerals.
98GF Score

Get the complete analysis for STC:IMP

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫42,050.00
Price
₫51,706.57
GF Value